Results 11 to 20 of about 640,542 (312)

Skin cancer prevention [PDF]

open access: yesJDDG: Journal der Deutschen Dermatologischen Gesellschaft, 2013
SummaryPrevention signifies the avoidance of diseases. It also includes the early detection of diseases and taking measures to avoid worsening of an existing disease. Prevention is divided into primary, secondary and tertiary prevention.The prevention of skin cancer is particularly important due to the rising incidence of skin cancer in recent years ...
Thomas, Kornek, Matthias, Augustin
openaire   +2 more sources

Viruses and Skin Cancer [PDF]

open access: yesInternational Journal of Molecular Sciences, 2021
Advances in virology and skin cancer over recent decades have produced achievements that have been recognized not only in the field of dermatology, but also in other areas of medicine. They have modified the therapeutic and preventive solutions that can be offered to some patients and represent a significant step forward in our knowledge of the biology
Sara Becerril   +8 more
openaire   +3 more sources

BET inhibitors synergize with sunitinib in melanoma through GDF15 suppression

open access: yesExperimental and Molecular Medicine, 2023
Cancer: a drug combination for combating melanoma Drugs that target proteins involved in issuing stop and start commands to cancer-related genes help to sensitize melanoma cells to a widely used anti-cancer therapy, leading to tumor shrinkage in mice ...
Furong Zeng   +7 more
doaj   +1 more source

Enrichment of Human Dermal Stem Cells from Primary Cell Cultures through the Elimination of Fibroblasts

open access: yesCells, 2023
Dermal stem cells (DSCs), which are progenitor cells of melanocytes, are isolated from human foreskin and cultivated as mixed cultures containing both DSCs and fibroblasts in varying proportions.
Christin Starzonek   +8 more
doaj   +1 more source

Patients with melanoma of unknown primary show better outcome under immune checkpoint inhibitor therapy than patients with known primary: preliminary results

open access: yesOncoImmunology, 2019
Background: Melanoma of unknown primary (MUP) is an uncommon clinical subtype of melanoma of known primary (MKP). Objectives: We aimed to compare treatment outcomes of MUP and MKP patients who had undergone therapy with immune checkpoint inhibitors (ICPI)
Thilo Gambichler   +4 more
doaj   +1 more source

The Role of Myeloid-Derived Suppressor Cells (MDSC) in Cancer Progression

open access: yesVaccines, 2016
The immunosuppressive tumor microenvironment represents not only one of the key factors stimulating tumor progression but also a strong obstacle for efficient tumor immunotherapy.
Viktor Umansky   +3 more
doaj   +1 more source

Nonmelanoma skin cancer

open access: yesJournal of Cutaneous and Aesthetic Surgery, 2012
Nonmelanoma skin cancer (NMSC) represents the most common form of cancer in Caucasians, with continuing increase in incidence worldwide. Basal cell carcinoma (BCC) accounts for 75% of cases of NMSC, and squamous cell carcinoma (SCC) accounts for the remaining majority of NMSC cases.
Samarasinghe, Venura, Madan, Vishal
openaire   +4 more sources

Clinical, dermoscopic and histopathologic findings of retiform hemangioendothelioma

open access: yesDermatology Practical & Conceptual, 2013
Retiform hemangioendothelioma (RH) is an uncommon vascular neoplasm of borderline malignancy that clinically develops as a solitary, gradually enlarging exophytic mass, nodule or plaque, most often on the lower limbs, upper limbs and trunk.
Amanda Mota   +6 more
doaj   +1 more source

Paraneoplastic hyperleucocytosis in a melanoma patient after initiation of ipilimumab and nivolumab combination therapy

open access: yesJournal for ImmunoTherapy of Cancer, 2018
Background Paraneoplastic hyperleucocytosis (PH) is sporadically seen in patients with advanced solid tumors. Case presentation We report a female patient with disseminated melanoma metastases.
Thilo Gambichler   +2 more
doaj   +1 more source

SOX2 and cancer: current research and its implications in the clinic

open access: yesClinical and Translational Medicine, 2014
SOX2 is a gene that encodes for a transcription factor belonging to the SOX gene family and contains a high‐mobility group (HMG) domain, which permits highly specific DNA binding.
Kasia Weina, Jochen Utikal
doaj   +1 more source

Home - About - Disclaimer - Privacy